GPCR Signaling and Vascular Wall Remodeling
GPCR 信号传导和血管壁重塑
基本信息
- 批准号:9312305
- 负责人:
- 金额:$ 47.59万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-04-01 至 2020-06-30
- 项目状态:已结题
- 来源:
- 关键词:ARHGEF1 geneATF2 geneATP binding cassette transporter 1ATP-Binding Cassette TransportersAddressApolipoprotein EApplications GrantsArterial Fatty StreakAtherosclerosisAttenuatedBlood PlateletsBlood VesselsBlood coagulationCD36 geneCause of DeathChemotactic FactorsCholesterolChronic DiseaseClustered Regularly Interspaced Short Palindromic RepeatsComplexDataDissociationDominant-Negative MutationDoseEMSAEndothelial CellsEnvironmental Risk FactorEventFibroblastsFoam CellsFunctional disorderFundingG Protein-Coupled Receptor SignalingGAB1 geneGenetic RiskInflammationKnowledgeLesionLinkLuciferasesMediatingMessenger RNAMitogensMusMuscle CellsMyocardial InfarctionPAR-1 ReceptorPathogenesisPeritoneal MacrophagesPharmacologyPlayProteinase-Activated ReceptorsProteinsPubMedRegulatory ElementReportingRoleSerine ProteaseSignal TransductionSite-Directed MutagenesisSmall Interfering RNASmooth Muscle MyocytesSocietiesStrokeTestingThrombinThrombosisThrombusTime StudyUbiquitinationVascular DiseasesVascular Smooth Muscleatherogenesisatherothrombosisbasecell typecholesterol transporterschromatin immunoprecipitationcullin-3experimental studyfeedinginsightmacrophagemigrationmonocytemortalitynoveloverexpressionoxidized lipidoxidized low density lipoproteinpromoterreceptorresponsescaffoldscavenger receptortranslational impactubiquitin-protein ligaseuptakewestern diet
项目摘要
Atherosclerosis is a chronic disease of arterial wall caused by various genetic and environmental risk factors
and is the foremost cause of mortality worldwide. Inflammation plays a critical role in atherogenesis. Protease-
activated receptor 1 (Par1) that mediates the cellular effects of thrombin, a serine protease, has been reported
to play an important role in inflammation. In addition, a large body of data suggests that Par1 plays an
essential role in atherothrombosis. Despite the role of Par1 in inflammation and atherothrombosis and the fact
that increased expression of Par1 is observed in atherosclerotic plaques, nothing is known about its role in
atherogenesis. In this context, we recently discovered that thrombin induces the expression of CD36, a
scavenger receptor linked to oxLDL uptake and foam cell formation, and this event requires Gα12/13, Pyk2,
Gab1, PKCθ and ATF2 activation downstream to Par1. In addition, we found that thrombin induces the
depletion of ABCA1, a reverse cholesterol transporter and attenuates cholesterol efflux. Interestingly, ABCA1
was found to exist in complex with GSK3β and, upon treatment with thrombin, it dissociates from GSK3β,
associates with cullin 3, a component of E3 ligases, and undergoes degradation. Based on these novel
observations, we hypothesize that thrombin-Par1 axis plays a major role in atherogenesis. To test this central
hypothesis, we propose to address the following three specific aims: Specific Aim 1: Par1 plays a central role
in atherogenesis. Specific Aim 2: PKCθ via activating ATF2 and enhancing CD36 expression, oxLDL uptake
and foam cell formation plays a crucial role in atherogenesis. Specific Aim 3: Overexpression of GSK3β
stabilizes ABCA1, enhances cholesterol efflux and protects from atherogenesis. The results of the proposed
studies will provide new mechanistic insights into the pathophysiology of atherosclerosis and explore the
translational impact of thrombin-Par1 signaling in this debilitating vascular disease.
动脉粥样硬化是由多种遗传和环境危险因素引起的动脉壁慢性疾病
炎症是导致动脉粥样硬化的主要原因。
据报道,激活的受体 1 (Par1) 介导凝血酶(一种丝氨酸蛋白酶)的细胞作用
此外,大量数据表明 Par1 在炎症中发挥着重要作用。
尽管 Par1 在炎症和动脉粥样硬化血栓形成中发挥着重要作用。
尽管在动脉粥样硬化斑块中观察到 Par1 表达增加,但对其在动脉粥样硬化斑块中的作用尚不清楚。
在这种情况下,我们最近发现凝血酶诱导 CD36 的表达,CD36 是一种
清道夫受体与 oxLDL 摄取和泡沫细胞形成相关,该事件需要 Gα12/13、Pyk2、
Par1 下游的 Gab1、PKCθ 和 ATF2 激活此外,我们发现凝血酶诱导
ABCA1(一种反向胆固醇转运蛋白)的消耗并减弱胆固醇流出。
被发现与 GSK3β 形成复合物,并且在用凝血酶处理后,它与 GSK3β 解离,
与 E3 连接酶的一个组成部分 cullin 3 结合,并根据这些小说进行降解。
根据观察,我们认为凝血酶-Par1 轴在动脉粥样硬化形成中起主要作用,以测试这一中枢。
假设,我们建议解决以下三个具体目标: 具体目标 1:Par1 发挥核心作用
具体目标 2:PKCθ 通过激活 ATF2 和增强 CD36 表达、oxLDL 摄取
泡沫细胞的形成在动脉粥样硬化形成中起着至关重要的作用。 具体目标 3:GSK3β 的过度表达。
稳定 ABCA1,增强胆固醇流出并防止动脉粥样硬化。
研究将为动脉粥样硬化的病理生理学提供新的机制见解并探索
凝血酶-Par1 信号转导在这种使人衰弱的血管疾病中的翻译影响。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GADIPARTHI N RAO其他文献
GADIPARTHI N RAO的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GADIPARTHI N RAO', 18)}}的其他基金
相似国自然基金
活体双生物发光成像监测JNK/c-Jun:ATF2信号通路介导的肿瘤顺铂耐药
- 批准号:81771879
- 批准年份:2017
- 资助金额:55.0 万元
- 项目类别:面上项目
激活转录因子2(ATF2)对具有不同P53基因状态胃癌细胞的影响及在胃癌个体化治疗中的意义
- 批准号:81702383
- 批准年份:2017
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Peptide therapy for alcohol-induced CNS injury
肽疗法治疗酒精引起的中枢神经系统损伤
- 批准号:
10572298 - 财政年份:2023
- 资助金额:
$ 47.59万 - 项目类别:
The role of Immune-responsive gene 1 and itaconate in atherosclerotic disease
免疫反应基因1和衣康酸在动脉粥样硬化疾病中的作用
- 批准号:
10607641 - 财政年份:2023
- 资助金额:
$ 47.59万 - 项目类别:
Mechanism of innate immune activation in a Drosophila model of Alzheimer's disease related dementia
阿尔茨海默病相关痴呆果蝇模型中先天免疫激活机制
- 批准号:
10339866 - 财政年份:2022
- 资助金额:
$ 47.59万 - 项目类别:
Mechanism of innate immune activation in a Drosophila model of Alzheimer's disease related dementia
阿尔茨海默病相关痴呆果蝇模型中先天免疫激活机制
- 批准号:
10554427 - 财政年份:2022
- 资助金额:
$ 47.59万 - 项目类别:
Function and regulation of Letmd1 in metabolic signaling
Letmd1在代谢信号中的功能和调节
- 批准号:
10553356 - 财政年份:2022
- 资助金额:
$ 47.59万 - 项目类别: